Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8004
Title: | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review |
Authors: | Bikdeli, B.;Madhavan, M. V.;Jimenez, D.;Chuich, T.;Dreyfus, I.;Driggin, E.;Nigoghossian, C.;Ageno, W.;Madjid, M.;Guo, Y.;Tang, L. V.;Hu, Y.;Giri, J.;Cushman, M.;Quere, I.;Dimakakos, E. P.;Gibson, C. M.;Lippi, G.;Favaloro, Emmanuel J.;Fareed, J.;Caprini, J. A.;Tafur, A. J.;Burton, J. R.;Francese, D. P.;Wang, E. Y.;Falanga, A.;McLintock, C.;Hunt, B. J.;Spyropoulos, A. C.;Barnes, G. D.;Eikelboom, J. W.;Weinberg, I.;Schulman, S.;Carrier, M.;Piazza, G.;Beckman, J. A.;Steg, P. G.;Stone, G. W.;Rosenkranz, S.;Goldhaber, S. Z.;Parikh, S. A.;Monreal, M.;Krumholz, H. M.;Konstantinides, S. V.;Weitz, J. I.;Lip, G. Y. H. |
WSLHD Author: | Favaloro, Emmanuel J. |
Issue Date: | 2020 |
Citation: | Journal of the American College of Cardiology 75(23):2950-2973, 2020 |
Abstract: | Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis. In addition, many patients receiving antithrombotic therapy for thrombotic disease may develop COVID-19, which can have implications for choice, dosing, and laboratory monitoring of antithrombotic therapy. Moreover, during a time with much focus on COVID-19, it is critical to consider how to optimize the available technology to care for patients without COVID-19 who have thrombotic disease. Herein, the authors review the current understanding of the pathogenesis, epidemiology, management, and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, of those with pre-existing thrombotic disease who develop COVID-19, or those who need prevention or care for their thrombotic disease during the COVID-19 pandemic. |
URI: | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8004 |
DOI: | https://dx.doi.org/10.1016/j.jacc.2020.04.031 |
Journal: | Journal of the American College of Cardiology |
Type: | Journal Article |
Study or Trial: | Research Support, N.I.H., Extramural Review |
Facility: | Westmead |
Keywords: | Anticoagulants Covid-19 Fibrinolytic Agents Pandemics Thromboembolism |
Appears in Collections: | Westmead Hospital 2019 - 2024 |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.